• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
629.4942217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
66.91
178151.98
EPS(TTM)
Face Value()
Div & Yield %
100.29
2
0.45
 

ARSS Infrastructure Projects reports consolidated net loss of Rs 210.53 crore in the March 2026 quarter
Jun 01,2026
Net Loss of ARSS Infrastructure Projects reported to Rs 210.53 crore in the quarter ended March 2026 as against net loss of Rs 9.50 crore during the previous quarter ended March 2025. Sales rose 204.92% to Rs 77.45 crore in the quarter ended March 2026 as against Rs 25.40 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3553.57 crore in the year ended March 2026 as against net loss of Rs 7.77 crore during the previous year ended March 2025. Sales declined 11.85% to Rs 145.79 crore in the year ended March 2026 as against Rs 165.39 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales77.4525.40 205 145.79165.39 -12
OPM %11.57-42.95 --77.68-8.04 -
PBDT1.32-8.82 LP -115.95-5.65 -1952
PBT0.97-9.07 LP -117.07-6.63 -1666
NP-210.53-9.50 -2116 -3553.57-7.77 -45634